Literature DB >> 26520637

Epilepsy, excess deaths and years of life lost from external causes.

Olli Nevalainen1,2, Mikko Simola3, Hanna Ansakorpi3, Jani Raitanen4,5, Miia Artama6, Jouko Isojärvi3,7, Anssi Auvinen4,8.   

Abstract

We systematically quantified excess mortality in epilepsy patients by cause of death using the population-attributable fraction and epilepsy-attributable years of potential life lost (YPLL) by age 75 years at ages 15 and over. We updated and undertook a re-review of mortality studies from our previous systematic review following PRISMA guidelines to identify cohort studies of general epilepsy populations reporting a relative risk (RR) of death by cause relative to the background rates in the population. Studies on epilepsy prevalence were identified through published reviews. Country-specific mortality figures were obtained from the WHO World Mortality Database. We performed a pooled analysis with the DerSimonian-Laird random effects method. In countries with very high Human Development Indices, epilepsy contributed to 0.5-1.1 % of all deaths in the total population. Among external causes, suicides (RR 2.9, 95 % confidence interval 2.2-3.8; I(2) 52 %) were the major contributor to YPLL, corresponding to 6.7 % and 4.2 % of excess YPLL due to epilepsy in the United States (US) and in the United Kingdom (UK) in 2010, with 541 (346-792) and 44 (28-65) excess suicide cases, respectively. Fatal accidental falls were more common, with 813 (610-1064) and 95 (71-125) excess deaths in the US and in the UK, but these caused only 2.0 % of excess YPLL as they occurred in older age groups. Suicides were the most important external cause of death in epilepsy patients in terms of excess YPLL, whereas other external causes were either more common in older ages or caused less excess deaths.

Entities:  

Keywords:  Epidemiology; Epilepsy; Meta-analysis; Mortality

Mesh:

Year:  2015        PMID: 26520637     DOI: 10.1007/s10654-015-0095-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  53 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  The epidemiology of epilepsy in Europe - a systematic review.

Authors:  L Forsgren; E Beghi; A Oun; M Sillanpää
Journal:  Eur J Neurol       Date:  2005-04       Impact factor: 6.089

Review 3.  Antiepileptic drugs and suicide: a systematic review of adverse effects.

Authors:  Pili Ferrer; Elena Ballarín; Mònica Sabaté; Xavier Vidal; Marietta Rottenkolber; Justyna Amelio; Joerg Hasford; Sven Schmiedl; Luisa Ibáñez
Journal:  Neuroepidemiology       Date:  2014-01-03       Impact factor: 3.282

4.  Cause-specific mortality in adults with unprovoked seizures. A population-based incidence cohort study.

Authors:  V Rafnsson; E Olafsson; W A Hauser; G Gudmundsson
Journal:  Neuroepidemiology       Date:  2001-10       Impact factor: 3.282

5.  Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Steen Zabell Abildstrøm; Jesper Erdal; Gunnar H Gislason; Peter Weeke; Charlotte Andersson; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-07-18       Impact factor: 2.890

6.  Long-term mortality in childhood-onset epilepsy.

Authors:  Matti Sillanpää; Shlomo Shinnar
Journal:  N Engl J Med       Date:  2010-12-23       Impact factor: 91.245

Review 7.  Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis.

Authors:  Olli Nevalainen; Hanna Ansakorpi; Mikko Simola; Jani Raitanen; Jouko Isojärvi; Miia Artama; Anssi Auvinen
Journal:  Neurology       Date:  2014-10-22       Impact factor: 9.910

8.  Sudden unexpected death in epilepsy: assessing the public health burden.

Authors:  David J Thurman; Dale C Hesdorffer; Jacqueline A French
Journal:  Epilepsia       Date:  2014-06-05       Impact factor: 5.864

9.  Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort.

Authors:  S D Lhatoo; A L Johnson; D M Goodridge; B K MacDonald; J W Sander; S D Shorvon
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

10.  Risk of mortality among patients with epilepsy in southern Taiwan.

Authors:  Ya-Hui Chang; Wen-Chao Ho; Jing-Jane Tsai; Chung-Yi Li; Tsung-Hsueh Lu
Journal:  Seizure       Date:  2012-02-08       Impact factor: 3.184

View more
  8 in total

1.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

2.  LncRNA MEG3 Reduces Hippocampal Neuron Apoptosis via the PI3K/AKT/mTOR Pathway in a Rat Model of Temporal Lobe Epilepsy.

Authors:  Hongyan Zhang; Jiuyun Tao; ShuXia Zhang; XinXin Lv
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-28       Impact factor: 2.570

Review 3.  Role of conventional magnetic resonance imaging in the screening of epilepsy with structural abnormalities: a pictorial essay.

Authors:  Xu Zhao; Zhiqiang Zhou; Wenzhen Zhu; Hongbing Xiang
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

4.  CNTF-Treated Astrocyte Conditioned Medium Enhances Large-Conductance Calcium-Activated Potassium Channel Activity in Rat Cortical Neurons.

Authors:  Meiqun Sun; Hongli Liu; Huanbai Xu; Hongtao Wang; Xiaojing Wang
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

5.  Involvement of upregulation of miR-210 in a rat epilepsy model.

Authors:  Licheng Chen; Hao Zheng; Shimeng Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-13       Impact factor: 2.570

6.  Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.

Authors:  Saku Väätäinen; Erkki Soini; Jukka Peltola; Mata Charokopou; Maarit Taiha; Reetta Kälviäinen
Journal:  Adv Ther       Date:  2019-12-05       Impact factor: 3.845

7.  Cause of death in patients with poststroke epilepsy: Results from a nationwide cohort study.

Authors:  Julia Hansen; Signild Åsberg; Eva Kumlien; Johan Zelano
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

Review 8.  Identifying Risk Factors Associated with Fatal Drowning Accidents in the Paediatric Population: A Review of International Evidence.

Authors:  Martin Davey; Sean Callinan; Leona Nertney
Journal:  Cureus       Date:  2019-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.